Catalogo dei prodotti della ricerca

POCE, Giovanna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.162
EU - Europa 965
AS - Asia 648
SA - Sud America 29
AF - Africa 15
Totale 4.819
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.108
IT - Italia 420
SG - Singapore 226
IN - India 199
CN - Cina 179
UA - Ucraina 128
FI - Finlandia 111
SE - Svezia 107
GB - Regno Unito 54
CA - Canada 46
DE - Germania 42
AR - Argentina 27
BG - Bulgaria 25
IE - Irlanda 22
RO - Romania 14
TW - Taiwan 13
BE - Belgio 12
ID - Indonesia 10
AT - Austria 7
ZA - Sudafrica 7
IR - Iran 6
MX - Messico 5
NL - Olanda 5
PL - Polonia 5
ME - Montenegro 4
TR - Turchia 4
BB - Barbados 3
FR - Francia 3
PK - Pakistan 3
SY - Repubblica araba siriana 3
TG - Togo 3
BR - Brasile 2
DK - Danimarca 2
EG - Egitto 2
RU - Federazione Russa 2
SA - Arabia Saudita 2
SC - Seychelles 2
AL - Albania 1
CH - Svizzera 1
CI - Costa d'Avorio 1
JP - Giappone 1
KR - Corea 1
MY - Malesia 1
Totale 4.819
Salva come PNG Salva come JPEG
Città #
Fairfield 410
Chandler 289
Ashburn 266
Woodbridge 239
Rome 215
Houston 199
Seattle 174
Ann Arbor 165
Cambridge 151
Beijing 150
Singapore 147
Wilmington 143
Princeton 91
Plano 77
New York 72
Boston 61
San Paolo di Civitate 48
Jacksonville 46
Lawrence 39
Helsinki 38
San Diego 35
Santa Clara 32
Andover 28
Federal 27
Ottawa 26
Des Moines 25
Millbury 25
Sofia 24
Boardman 22
Dublin 22
Toronto 18
Washington 18
Milan 17
Norwalk 17
Naples 15
Brussels 12
Pune 12
Taipei 12
Oxford 11
Florence 10
Mannheim 7
Falls Church 6
Hefei 6
Johannesburg 6
Bozzolo 5
Bühl 5
Fuzhou 5
San Mateo 5
Trieste 5
Vienna 5
Auburn Hills 4
Dearborn 4
Hounslow 4
Banda Aceh 3
Berlin 3
Bridgetown 3
Buffalo 3
Hyderabad 3
Lomé 3
Los Angeles 3
Magenta 3
Mentana 3
Nanjing 3
Pekanbaru 3
Southend 3
Velletri 3
Alexandria 2
Ancona 2
Atlanta 2
Cassino 2
Civitavecchia 2
Codroipo 2
Crna Gora 2
Fasano 2
Frascati 2
Fremont 2
Henderson 2
Istanbul 2
Jakarta 2
Jinan 2
Karachi 2
Karaj 2
Kochi 2
Kunming 2
León 2
Mexico City 2
Padova 2
Pessac 2
Pontianak 2
Porto Alegre 2
Randers 2
Redmond 2
Shenyang 2
Siena 2
Timisoara 2
Turin 2
Abidjan 1
Albano Laziale 1
Arnsberg 1
Bern 1
Totale 3.598
Salva come PNG Salva come JPEG
Nome #
A novel antimycobacterial compound acts as an intracellular iron chelator 140
Activity of lipophilic and hydrophilic drugs against dormant and replicating mycobacterium tuberculosis 124
In vivo potent BM635 analogue with improved drug-like properties 100
A series of COX-2 inhibitors endowed with NO-releasing properties: synthesis, biological evaluation, and docking analysis 94
Novel therapies for glaucoma: a patent review (2013-2019) 92
A class of pyrrole derivatives endowed with analgesic/anti-inflammatory activity 88
Mycobacterial tryptophan biosynthesis: a promising target for tuberculosis drug development? 88
1,5-Diarylpyrroles as potent antitubercular and anti-inflammatory agents 86
Dietary flavonoids: Nano delivery and nanoparticles for cancer therapy 86
MmpL3 Is the Cellular Target of the Antitubercular Pyrrole Derivative BM212 85
Developing Pyrrole-Derived Antimycobacterial Agents: a Rational Lead Optimization Approach 84
Antimycobacterial compounds. Optimization of the BM 212 structure, the lead compound for a new pyrrole derivative class 81
COX inhibitors: a patent review (2011 - 2014) 81
Synthesis and biological evaluation of fluorinated 1,5-diarylpyrrole-3-alkoxyethyl ether derivatives as selective COX-2 inhibitors endowed with anti-inflammatory activity 79
MmpL3 inhibitors: diverse chemical scaffolds inhibit the same target 79
SAR analysis of new anti-TB drugs currently in pre-clinical and clinical development 73
Novel pyrazole-containing compounds active against mycobacterium tuberculosis 73
C-9 Alkenylidine bridged macrolides: WO2008061189. 71
MmpL3 is the flippase for mycolic acids in mycobacteria 71
1,5-Diphenyl Pyrrole Derivatives as Antimycobacterial Agents. Probing the Influence on Antimycobacterial Activity of Lipophilic Substituents at the Phenyl Rings 69
1,5-Diaryl-2-ethyl pyrrole derivatives as antimycobacterial agents: design, synthesis, and microbiological evaluation 69
Identification of a novel pyrrole derivative endowed with antimycobacterial activity and protection index comparable to that of the current antitubercular drugs streptomycin and rifampin 67
Novel Analgesic/Anti-Inflammatory Agents: Diarylpyrrole Acetic Esters Endowed with Nitric Oxide Releasing Properties 67
Improving the solubility of a new class of antiinflammatory pharmacodynamic hybrids, that release nitric oxide and inhibit cycloxygenase-2 isoenzyme 67
Enhancing the pharmacodynamic profile of a class of selective COX-2 inhibiting nitric oxide donors 66
Enlarging the NSAIDs Family: Ether, Ester and Acid Derivatives of the 1,5-Diarylpyrrole Scaffold as Novel Anti-Inflammatory and Analgesic Agents 66
1,5-diarylpyrrole-3-acetic acids and esters as novel class of potent and selective COX-2 inhibitors. 64
Sar analysis of small molecules interfering with energy-metabolism in mycobacterium tuberculosis 64
New 1,5-diarylpyrrole with improved antimycobacterial activity 63
New pyrroles with potential antimycobacterial, antifungal and COX-2 selective inhibiting activities. Synthetic methodologies 63
Direct-Acting Antivirals and Host-Targeting Approaches against Enterovirus B Infections: Recent Advances 62
HPLC Enantioseparation and Absolute Configuration of Novel Antiinflammatory Pyrrole Derivatives 62
Novel Analgesic/Anti-inflammatory Agents: 1,5-Diarylpyrrole Nitro-oxyalkyl Ethers and Related Compounds as Cyclooxygenase-2 Inhibiting Nitric Oxide Donors 61
Chocolate consumers and lymphocyte-to-monocyte ratio: a working hypothesis from a preliminary report of a pilot study in celiac subjects 61
New oxazolidinone derivatives as antibacterial agents with improved activity 59
Synthesis, in vitro, and in vivo biological evaluation and molecular docking simulations of chiral alcohol and ether derivatives of the 1,5-diarylpyrrole scaffold as novel anti-inflammatory and analgesic agents 58
The novel anti-inflammatory agent VA694, endowed with both NO-releasing and COX2-selective inhibiting properties, exhibits NO-mediated positive effects on blood pressure, coronary flow and endothelium in an experimental model of hypertension and endothelial dysfunction 56
Nano-based drug delivery systems of potent MmpL3 inhibitors for tuberculosis treatment 55
Pyrrole Derivatives as New Antimycobacterial Class: Synthesis, S.A.R., Molecular Modelling Considerations and Microbiological Activity 55
One-pot conversions of olefins to cyclic carbonates and secondary allylic and homoallylic amines to cyclic carbamates 55
Malaria transmission blocking compounds: a patent review 55
Antimycobacterial agents. Novel diarylpirrole derivatives of BM212 endowed with high activity toward Mycobacterium tuberculosis and low cytotoxicity 53
BM212 and its derivatives: lead optimization of a new class of antimycobacterial agents. 52
Improved BM212 MmpL3 Inhibitor Analogue Shows Efficacy in Acute Murine Model of Tuberculosis Infection 51
null 51
null 51
A novel class of dual-acting DCH-CORMs counteracts oxidative stress-induced inflammation in human primary tenocytes 51
Antiviral Mechanisms of N-Phenyl Benzamides on Coxsackie Virus A9 50
Identification of a new chemical class of potent antimycobacterial compounds derived from BM 212: design, synthesis, biological evaluation and study of their mode of action. 50
New Pyrrole-based selective COX-2 inhibiting nitric oxide donors: synthesis, in vitro and in vivo evaluation 50
Cyclooxygenase-2 Inhibitors. 1,5-Diarylpyrrol-3-acetic Esters with Enhanced Inhibitory Activity toward Cyclooxygenase-2 and Improved Cyclooxygenase-2/Cyclooxygenase-1 Selectivity 50
Doubly diastereoselective conjugate addition of enantiopure lithium amides to enantiopure N-enoyl oxazolidin-2-ones: a mechanistic probe 48
6-Fluorophenylbenzohydrazides inhibit Mycobacterium tuberculosis growth through alteration of tryptophan biosynthesis 47
Inhibition of Leishmania infantum trypanothione reductase by azole-based compounds: a comparative analysis with its physiological substrate by X-ray crystallography 46
1,5-Diaryl-Pyrroles as New Generation of Anti-Inflammatory and Analgesic Agents: Design, Synthesis, in vitro and in vivo Evaluation 45
Synthesis of new pyrrole derivatives of BM 212, a potent antimycobacterial compound 44
New derivatives of BM 212 with improved antimycobacterial activity. 44
Potent in vitro and in vivo novel 1,5-Diarylpyrrole-3-acetic Esters COX-2 inhibitors. 43
Developing New Antiinflammatory and Analgesic Agents: Design, Synthesis, Biological and harmacological Evaluation 42
Derivatives of BM 212: synthesis and biological evaluation of new derivatives with improved antimycobacterial activity. 41
Therapeutic potential for coxibs-nitric oxide releasing hybrids in cystic fibrosis 40
New 1,5-diphenyl pyrrole derivatives as anti-inflammatory COX-2 selective compounds and their use as potential antitumoral agents. 39
Analogs of BM 212: a new chemical class of antimycobacterial agents acting upon a new target 39
1,5-Diphenyl pyrroles as new antimycobacterial agents. Hit-to-lead development and target validation, New drugs for neglected diseases 37
Overcoming drug resistance in TB: an update 37
1,5-DIARYLPYRROLE-3-ACETIC ACIDS AND ESTERS AS NOVEL CLASSES OF POTENT AND SELECTIVE COX-2 INHIBITORS. 36
BM212 targets MmpL3, Gordon Research Conference on Tuberculosis Drug Development 36
1,5-DIARYLPYRROLE DERIVATIVESAS NOVEL CLASSES OF ACTIVE AND SELECTIVE COX-2 INHIBITORS. 34
Nano-Based Drug Delivery Systems of Potent MmpL3 Inhibitors for Tuberculosis Treatment 34
Design and synthesis of 1,5-diaryl-2-ethyl pyrrole derivatives and their evaluation as antimycobacterial agents 32
Design and Synthesis of novel diarylpyrroles as p38 MAP kinase inhibitors 32
BM212 and new derivatives as a new class of antimycobacterial agents. 31
Stimuli-responsive tannin–feIII hybrid microcapsules demonstrated by the active release of an anti-tuberculosis agent 31
ENANTIOMERS OF NOVEL ANTIINFLAMMATORY PYRROLE DERIVATIVES:ANALYTICAL AND SEMIPREPARATIVE HPLC SEPARATION AND CHIROPTICAL PROPERTIES. 30
New 1,5 diarylpyrrole derivatives as antimycobacterial agents: Design, synthesis, biological evaluation and study of their mode of action 30
Identification of a new Chemical Class of Potent Antimycobacterial Compounds 29
Amino Acid Biosynthesis Inhibitors in Tuberculosis Drug Discovery 28
New pyrrole derivatives of BM 212: lead compound optimization strategy, Tuberculosis drug development. Targets, technologies and trials 28
Pyrrole derivatives of BM212 as novel antimycobacterial agents Design, synthesis, biological evaluation and study of their mode of action 27
New 1,5-diphenyl pyrrole derived from BM 212: a new class of antimycobacterial Agents 27
Novel Ester and Acid Derivatives of the 1,5-Diarylpyrrole Scaffold as Anti-inflammatory and Analgesic Agents. Synthesis, in vitro and in vivo Biological Evaluation 27
New 1,5-diphenyl Pyrrole Derived from BM 212: a New class of Antimycobacterial Agents. 26
Novel inhibitors of Mycobacterium tuberculosis tryptophan biosynthetic pathway to treat tuberculosis 26
Synthesis and biological evaluation of new heterocyclic derivatives with potential antimycobacterial activity: systematic approach to lead compound optimization 23
Pyrrole-based selective COX-2 inhibiting nitric oxide donors: synthesis, in vitro and in vivo evaluation 23
New pyrrole derivatives of BM 212: a new class of antimycobacterial agents.Design, synthesis, biological evaluation and study of their mode of action. 22
null 22
New heterocyclic compounds with potential activity against parasitic protozoan: Trypanosoma and Leishmania 22
Development of MmpL3 inhibitors for tuberculosis treatment 21
BM 579: a novel pyrrole derivative with improved antimycobacterial activity 18
New pyrrole derivatives of BM 212: a new class of antimycobacterial agents. Design, synthesis, biological evaluation and study of their mode of action 18
New Heterocyclic Compounds Targeting Trypanothyione Metabolism in Leishmania Parasites 18
Design, synthesis and screening of new antitubercular agents derived from BM 212 17
New Pyrrole Derivatives as Anti-inflammatory and Analgesic Agents: Design, Synthesis and Biological Evaluation 16
Nuovi derivati 1,5-difenilpirrolici derivati del BM212 attivi come agenti antitubercolari 16
Synthesis, biological evaluation and docking analysis of a new series of methylsulfonyl and sulfamoyl acetamides and ethyl acetates as potent COX-2 inhibitors 14
Pharmaceutical salt of BM635 with improved bioavailability 14
Tannin microcapsules for synergy-enhanced sunscreen formulations 9
Overcoming drug resistance for tuberculosis, 8
Transmission-Blocking Strategies for Malaria Eradication: Recent Advances in Small-Molecule Drug Development 3
Totale 4.968
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.168
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.168
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020810 0 0 16 39 73 100 107 117 99 149 77 33
2020/2021434 61 44 19 36 8 23 10 47 46 78 49 13
2021/2022832 10 54 81 32 117 19 20 74 84 70 83 188
2022/2023948 190 188 21 88 92 99 25 65 81 39 45 15
2023/2024674 39 84 44 50 62 173 26 59 9 52 28 48
2024/2025238 41 124 73 0 0 0 0 0 0 0 0 0
Totale 4.968